Hybridoma Technology
Drug Products: Biologics, Biosimilars and Interchangeables
Antibody Actions
Humoral Immune Responses
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 20, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
Published on: January 24, 2017
Kevin J Whaley1, Josh Morton, Steve Hume
1Mapp Biopharmaceutical Inc, 6160 Lusk Blvd, Suite C105, San Diego, CA, 92121, USA, Kevin.whaley@mappbio.com.
Plant virus-based expression offers a cost-effective and faster alternative for producing antibody-based products, addressing global health challenges. This technology enables scalable manufacturing with potential improvements in pharmacokinetics, safety, and efficacy.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: